Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome.
10 publications have been identified in PubMed for autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome. Research spans Case Report / Case Series (40%), Review / Meta-Analysis (20%), and Other (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 40% |
Data assembled from 3 of 12 sources · Last updated Sep 21, 2026, 4:52 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
2 |
20% |
Other research | 1 | 10% |
Testing and diagnosis research | 1 | 10% |
Laboratory research | 1 | 10% |
Disease patterns and progression | 1 | 10% |
Shaikh H (2026). [PMID: 30085557](https://pubmed.ncbi.nlm.nih.gov/30085557/). *Unknown Journal*. [Case Report / Case Series]
Soresina A (2025). [PMID: 40547444](https://pubmed.ncbi.nlm.nih.gov/40547444/). *EClinicalMedicine*. [Epidemiology / Natural History]
Sormani J (2025). [PMID: 41219619](https://pubmed.ncbi.nlm.nih.gov/41219619/). *J Clin Immunol*. [Case Report / Case Series]
Tobin JM (2024). [PMID: 39028870](https://pubmed.ncbi.nlm.nih.gov/39028870/). *J Exp Med*. [Other]
Mansour M (2024). [PMID: 39732732](https://pubmed.ncbi.nlm.nih.gov/39732732/). *J Med Case Rep*. [Case Report / Case Series]
Vélez N (2024). [PMID: 39836840](https://pubmed.ncbi.nlm.nih.gov/39836840/). *Biomedica*. [Review / Meta-Analysis]
Atas U (2024). [PMID: 39431027](https://pubmed.ncbi.nlm.nih.gov/39431027/). *North Clin Istanb*. [Case Report / Case Series]
Niehues T (2024). [PMID: 39381601](https://pubmed.ncbi.nlm.nih.gov/39381601/). *Allergol Select*. [Diagnostic / Biomarker]
Rao VK (2024). [PMID: 39644063](https://pubmed.ncbi.nlm.nih.gov/39644063/). *Hematology Am Soc Hematol Educ Program*. [Review / Meta-Analysis]
Gilton M (2024). [PMID: 39155467](https://pubmed.ncbi.nlm.nih.gov/39155467/). *Br J Haematol*. [Basic Science / Preclinical]